AI Bias Analysis
4 models · Takes ~15 seconds
Capricor Therapeutics has accused Nippon Shinyaku and its U.S. subsidiary of botching the rollout of a Duchenne muscular dystrophy treatment.
Source
Stat News
Opens original article in a new tab
(MedPage Today) -- The FDA on Friday issued guidance for manufacturers collecting postmarketing data on the safety of approved drugs and biologics in pregnancy, with the goal of better understanding potential risks for the pregnant patient and...
(MedPage Today) -- Inequities persisted among female nephrologists at U.S. academic institutions, with barriers to advancement and burnout among the reasons many felt a lack of satisfaction, an interim analysis of survey data showed. Among 32...
(MedPage Today) -- Hantaviruses do not spread easily between people, which makes health officials confident the recent outbreak on a cruise ship that has killed three people will not turn into an epidemic. But, still, they need to make sure. So...
(MedPage Today) -- You passed medical training, now see if you can pass our weekly quiz
